Residue histidine 669 is essential for the catalytic activity of Bacillus anthracis lethal factor

Journal of Bacteriology

Volumn 192, Issue 21, 2010, Pages 5799-5805

  Cao, Sha ^a   Guo, Aizhen ^a   Wu, Gaobing ^a   Liu, Ziduo ^a   Chen, Wei ^a   Feng, Chunfang ^a   Zhang, Cheng Cai ^b   Chen, Huanchun ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; HISTIDINE; ANTHRAX TOXIN; BACTERIAL ANTIGEN; BACTERIAL TOXIN; PROTEIN BINDING;

AMINO ACID SUBSTITUTION; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL VIRULENCE; CATALYSIS; CYTOTOXICITY; LETHAL GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SITE DIRECTED MUTAGENESIS; WILD TYPE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; MUTATION; PATHOLOGY; PHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE; SPLEEN;

BACILLUS ANTHRACIS;

ANIMALS; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; GENE EXPRESSION REGULATION, BACTERIAL; HISTIDINE; MICE; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; SPLEEN;

EID: 78049384875     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00485-10     Document Type: Article

References (38)

1. Abrami, L., N. Reig, and F. G. Goot. 2005. Anthrax toxin: the long and winding road that leads to the kill. Trends Microbiol. 13:72-78.
2. Arora, N. 1997. Site directed mutagenesis of histidine residues in anthrax toxin lethal factor binding domain reduces toxicity. Mol. Cell. Biochem. 177:7-14.
3. Arora, N., and S. H. Leppla. 1993. Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. J. Biol. Chem. 268:3334-3341.
4. Cao, S., Z. Liu, A. Guo, Y. Li, C. Zhang, G. Wu, C. Feng, Y. Tan, and H. Chen. 2008. Efficient production and characterization of Bacillus anthracis lethal factor and a novel inactive mutant rLFm-Y236F. Protein Expr. Purif. 59:25-30.
5. Cao, S., A. Guo, Z. Liu, Y. Tan, G. Wu, C. Zhang, Y. Zhao, and H. Chen. 2009. Investigation of new dominant-negative inhibitors of anthrax protective antigen mutants for use in therapy and vaccination. Infect. Immun. 77:4679-4687.
6. Chaudry, G., J. Moayeri, M. Liu, and S. H. Leppla. 2002. Quickening the pace of anthrax research: three advances point towards possible therapies. Trends Microbiol. 10:58-62.
7. Cheng, Y., C. Hsueh, S. Lu, and T. Liao. 2006. Identification of three crucial histidine residues (His115, His132 and His297) in porcine deoxyribonuclease II. Biochem. J. 398:177-185.
8. Chopra, A. P., S. A. Boone, X. Liang, and N. S. Duesbery. 2003. Anthrax lethal factor proteolysis and inactivation of MAPK kinase. J. Biol. Chem. 278:9402-9406.
9. Chou, J. C., W. H. Welch, and J. D. Cohen. 2004. His-404 and His-405 are essential for enzyme catalytic activities of a bacterial indole-3-acetyl-L- aspartic acid hydrolase. Plant Cell Physiol. 45:1335-1341.
10. Dixon, T. C., M. Meselson, J. Guillemin, and P. C. Hanna. 1999. Anthrax. N. Engl. J. Med. 341:815-826.
11. Duesbery, N. S., C. P. Webb, S. H. Leppla, V. M. Gordon, K. R. Klimpel, T. D. Copeland, N. G. Ahn, M. K. Oskarsson, K. Fukasawa, K. D. Paull, and G. V. Woude. 1998. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280:734-737.
12. Fujiwara, T., S. Aoki, H. Komatsuzawa, T. Nishida, M. Ohara, H. Suginaka, and M. Sugai. 2005. Mutation analysis of the histidine residues in the glycylglycine endopeptidase ALE-1. J. Bacteriol. 187:480-487. (Pubitemid 40096236)
13. Hammond, S. E., and P. C. Hanna. 1998. Lethal factor active-site mutations affect catalytic activity in vitro. Infect. Immun. 66:2374-2378.
14. Hye-jin, Y., Y. J. Choi, O. Miyake, W. Hashimoto, K. Mutata, and B. Mikami. 2001. Effect of His1992 mutation on the activity of alginate lyase A1-III from sphingomonas species A1. J. Microbiol. Biotechnol. 11:118-123.
15. Kim, J., Y. G. Chai, and M. Y. Yoon. 2004. Implication of pH in the catalytic properties of anthrax lethal factor. Biochem. Biophys. Res. Commun. 313:217-222.
16. Kintzer, A. F., H. J. Sterling, L. I. Tang, A. Abdul-Gader, A. J. Miles, B. A. Wallance, E. R. Williams, and B. A. Krantz. 2010. Role of the protective antigen octamer in the molecular mechanism of anthrax lethal toxin stabilization. J. Mol. Biol. 399:741-758.
17. Kintzer, A. F., K. L. Thoren, H. J. Sterling, K. C. Dong, G. K. Feld, I. I. Tang, E. R. Williams, J. M. Berger, and B. A. Krantz. 2009. The protective antigen component of anthrax toxin forms functional octameric complexes. J. Mol. Biol. 392:614-629.
18. Klimpel, K. R., N. Arora, and S. H. Leppla. 1994. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol. Microbiol. 13:1093-1100.
19. Kochi, S. K., G. Schiavo, M. Mock, and C. Montecucco. 1994. Zinc content of the Bacillus anthracis lethal factor. FEMS Microbiol. Lett. 124:343-348.
20. Kumar, P., N. Ahuja, and R. Bhatnagar. 2001. Purification of anthrax edema factor from Escherichia coli and identification of residues required for binding to anthrax protective antigen. Infect. Immun. 69:6532-6536.
21. Lacy, D. B., D. J. Wigelsworth, R. A. Melnyk, S. C. Harrison, and R. J. Collier. 2004. Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation. Proc. Natl. Acad. Sci. U. S. A. 101:13147-13151.
22. Lacy, D. B., M. Mourez, A. Fouassier, and R. J. Collier. 2002. Mapping the anthrax protective antigen binding site on the lethal and edema factors. J. Biol. Chem. 277:3006-3010.
23. Leppla, S. H., N. Arora, and M. Varughese. 1999. Anthrax toxin fusion proteins for intracellular delivery of macromolecules. J. Appl. Microbiol. 87:284.
24. Mock, M., and A. Fouet. 2001. Anthrax. Annu. Rev. Microbiol. 55:647-671.
25. Mogridge, J., M. Mourez, and R. J. Collier. 2001. Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin. J. Bacteriol. 183:2111-2116.
26. Montecucco, C., F. Tonello, and G. Zanotti. 2004. Stop the killer: how to inhibit the anthrax lethal factor metalloprotease. Trends Biochem. Sci. 29:282-285.
27. Mourez, M., D. B. Lacy, K. Cunningham, R. Legmann, B. R. Sellman, J. Mogridge, and R. J. Collier. 2002. 2001: a year of major advances in anthrax toxin research. Trends Microbiol. 10:287-293.
28. Pannifer, A. D., T. Y. Wong, R. Schwarzenbacher, M. Renatus, C. Petosa, J. Bienkowska, D. B. Lacy, R. J. Collier, S. Park, S. H. Leppla, P. Hanna, and R. C. Liddington. 2001. Crystal structure of the anthrax lethal factor. Nature 414:229-233.
29. Park, J. M., F. R. Greten, Z. W. Li, and M. Karin. 2002. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297:2048-2051.
30. Popov, S. G., R. Villasmil, J. Bernardi, E. Grene, J. Cardwell, A. Wu, D. Alibek, C. Bailey, and K. Alibek. 2002. Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem. Biophys. Res. Commun. 283:349-355.
31. Sanchez, A. M., and K. A. Bradley. 2004. Anthrax toxin: can a little be a good thing? Trends Microbiol. 12:143-145.
32. Tonello, F., L. Naletto, V. Romanello, F. D. Molin, and C. Montecucco. 2004. Tyrosine-728 and glutamic acid-735 are essential for the metalloproteolytic activity of the lethal factor of Bacillus anthracis. Biochem. Biophys. Res. Commun. 313:496-502.
33. Tonello, F., M. Seveso, O. Marin, M. Mock, and C. Montecucco. 2002. Screening inhibitors of anthrax lethal factor. Nature 418:386. (Pubitemid 34826833)
34. Tonello, F., P. Ascenzi, and C. Montecucco. 2003. The metalloproteolytic activity of the anthrax lethal factor is substrate-inhibited. J. Biol. Chem. 278:40075-40078.
35. Vitale, G., L. Bernardi, G. Napolitani, M. Mock, and C. Montecucco. 2000. Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem. J. 3:739-745. (Pubitemid 32015030)
36. Vitale, G., R. Pellizzari, C. Recchi, G. Napolitani, M. Mock, and C. Montecucco. 1998. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248:706-711.
37. Yan, M., and R. J. Collier. 2003. Characterization of dominant-negative forms of anthrax protective antigen. Mol. Med. 9:46-51.
38. Yan, M., M. H. Roehrl, E. Basar, and J. Y. Wang. 2008. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates. Vaccine 26:947-955.